Lumicell illuminates cancer and other diseased tissues at the molecular level, enabling physicians to take action in real-time during surgeries to improve patient outcomes. Lumicell’s technology is in late-stage development for breast cancer surgery, and is also being investigated in ovarian, prostate, brain, colorectal, esophageal, and pancreatic cancers. Additional future indications are planned to include perfusion, wound care and infection, and surgeries for lung and liver cancer.